Vigabatrin: Difference between revisions
From SEHK Wiki
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
'''Vigabatrin (SABRIL)'''（中文：[[氯己烯酸]]） | '''Vigabatrin (SABRIL)'''（中文：[[氯己烯酸]]） | ||
==Common Strengths of Vigabatrin== | |||
Vigabatrin are available in the following strengths: | |||
*Tablet: 500 mg | |||
==Drug Trade Names of Vigabatrin== | |||
Sabril | |||
==Drug Usage== | |||
Vigabatrin is used for: | |||
*Treatment of refractory complex partial seizures in adults and children aged 2 years and older. | |||
*Treatment of infantile spasms in infants aged 1 month to 2 years. | |||
==Mechanism of Action== | |||
Vigabatrin works by irreversibly inhibiting GABA transaminase, the enzyme responsible | |||
Revision as of 02:19, 29 August 2024
Drug class: Anticonvulsant
Vigabatrin (SABRIL)（中文：氯己烯酸）
Common Strengths of Vigabatrin
Vigabatrin are available in the following strengths:
- Tablet: 500 mg
Drug Trade Names of Vigabatrin
Sabril
Drug Usage
Vigabatrin is used for:
- Treatment of refractory complex partial seizures in adults and children aged 2 years and older.
- Treatment of infantile spasms in infants aged 1 month to 2 years.
Mechanism of Action
Vigabatrin works by irreversibly inhibiting GABA transaminase, the enzyme responsible
